التفاصيل البيبلوغرافية
| العنوان: |
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression. |
| المؤلفون: |
Nugent, Allison C, Carlson, Paul J, Bain, Earle E, Eckelman, William, Herscovitch, Peter, Manji, Husseini, Zarate, Carlos A, Drevets, Wayne C |
| المصدر: |
Journal of Psychopharmacology; Oct2013, Vol. 27 Issue 10, p894-902, 9p |
| مصطلحات موضوعية: |
SEROTONIN receptors, AFFECTIVE disorders, PSYCHOLOGICAL stress, MOOD stabilizers, LITHIUM, GLUCOCORTICOIDS, BIPOLAR disorder, POSITRON emission tomography, GENETICS |
| مستخلص: |
Abnormal serotonin type 1A (5-HT1A) receptor function and binding have been implicated in the pathophysiology of mood disorders. Preclinical studies have consistently shown that stress decreases the gene expression of 5-HT1A receptors in experimental animals, and that the associated increase in hormone secretion plays a crucial role in mediating this effect. Chronic administration of the mood stabilizers lithium and divalproex (valproate semisodium) reduces glucocorticoid signaling and function in the hippocampus. Lithium has further been shown to enhance 5-HT1A receptor function. To assess whether these effects translate to human subject with bipolar disorder (BD), positron emission tomography (PET) and [18F]trans-4-fluoro-N-(2-[4-(2-methoxyphenyl) piperazino]-ethyl)-N-(2-pyridyl) cyclohexanecarboxamide ([18F]FCWAY) were used to acquire PET images of 5-HT1A receptor binding in 10 subjects with BD, before and after treatment with lithium or divalproex. Mean 5-HT1A binding potential (BPP) significantly increased following mood stabilizer treatment, most prominently in the mesiotemporal cortex (hippocampus plus amygdala). When mood state was also controlled for, treatment was associated with increases in BPP in widespread cortical areas. These preliminary findings are consistent with the hypothesis that these mood stabilizers enhance 5-HT1A receptor expression in BD, which may underscore an important component of these agents’ mechanism of action. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Psychopharmacology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
